Symbol="ADVM"
AssetType="Common Stock"
Name="Adverum Biotechnologies Inc"
Description="Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops candidate gene therapy products to treat eye and rare diseases. The company is headquartered in Redwood City, California."
CIK="1501756"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="1035 O'BRIEN DRIVE, MENLO PARK, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="188075000"
EBITDA="-135722000"
PERatio="None"
PEGRatio="0"
BookValue="1.569"
DividendPerShare="0"
DividendYield="0"
EPS="-1.24"
RevenuePerShareTTM="0.036"
ProfitMargin="0"
OperatingMarginTTM="-39.56"
ReturnOnAssetsTTM="-0.261"
ReturnOnEquityTTM="-0.661"
RevenueTTM="3600000"
GrossProfitTTM="-81681000"
DilutedEPSTTM="-1.24"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.7"
AnalystTargetPrice="3.75"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="3419.85"
PriceToBookRatio="0.302"
EVToRevenue="3700.64"
EVToEBITDA="0.229"
Beta="0.806"
num_52WeekHigh="2.34"
num_52WeekLow="0.531"
num_50DayMovingAverage="1.493"
num_200DayMovingAverage="0.928"
SharesOutstanding="100575000"
DividendDate="None"
ExDividendDate="None"
symbol="ADVM"
open="1.96"
high="1.97"
low="1.76"
price="1.82"
volume="392051.00"
latest_trading_day="2023-07-27"
previous_close="1.97"
change="-0.15"
change_percent="-7.6142%"
aroon_positive_momentum_days="100"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="100"
Volume_recent_avg="526798"
Change_recent_avg="0.01"
Delta_recent_avg="0.1"
Variance_recent_avg="0.05"
Change_ratio_recent_avg="0.85"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="100"
Aroon_momentum_negative="0"
image_negative_thumbnail_id_1="96"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0080.jpeg"
image_negative_thumbnail_id_2="112"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0064.jpeg"
image_neutral_thumbnail_id_1="560"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0039.jpeg"
image_neutral_thumbnail_id_2="540"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0059.jpeg"
image_positive_thumbnail_id_1="674"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0034.jpeg"
image_positive_thumbnail_id_2="686"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0022.jpeg"
image_professor_thumbnail_id_1="1173"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0007.jpeg"
image_professor_thumbnail_id_2="1181"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0015.jpeg"
